A ‘Novel’ Anti-inflammatory “We discuss the concept of using low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain conditions that are suspected to be associated with inflammatory processes.” Low dose Naltrexone is...
Francesca Owens has really been through it. A fitness buff, she entered a fitness competition at age thirty-nine and won with 11.4% body fat and a fitness age of eighteen, but after becoming pregnant with her second child in 2001 something changed. By the summer of...
Fibromyalgia syndrome – Novel therapeutic agents. J. Ablin and D. Buskila. Maturitas 2013 “The long term follow-up of FMS patients indicates…..that the degree of improvement achieved by many medications…is modest at best” Ablin and Buskia...
RESEARCH AVENUES/POTENTIAL TREATMENTS (Please note I have no medical background am in no way qualified to recommend any particular course of treatment for ME/CFS. The following is a theoretical discussion that logically flows from the proposed neuroinflammatory...
In this second of two studies by Stanford researchers on low dose naltrexone’s effectiveness in Fibromyalgia (FM), LDN was found to significantly reduce pain and improve mood and quality of life. About 60% of study participants reported pain reductions of at...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.